METHOD OF TREATING A CONDITION USING A THERAPEUTICALLY EFFECTIVE DOSE OF THE MALT1 INHIBITOR JNJ -67856633 (1 -(1 -OXO-1,2-DIHYDROISOQUINOLIN-5-YL)-5-(TRIFLUOROMETHYL)-N-(2-(TRIFL UOROMETHYL)PYRIDIN-4-YL)-1 H-PY RAZOLE-4-CARBOXAMIDE)
The invention relates to a method of treating a disorder or condition that is affected by the inhibition of MALT1 in a subject in need of treatment, comprising administering a therapeutically effective dose of 1-(1-oxo-1,2-dihydroisoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French |
Published |
09.09.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The invention relates to a method of treating a disorder or condition that is affected by the inhibition of MALT1 in a subject in need of treatment, comprising administering a therapeutically effective dose of 1-(1-oxo-1,2-dihydroisoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]-1H-pyrazole-4-carboxamide (Compound A), or a solvate or pharmaceutically acceptable salt form thereof to said subject, wherein said therapeutically effective dose is defined in the specification.
L'invention concerne une méthode de traitement d'un trouble ou d'une affection qui est influencée par l'inhibition de MALT1 chez un patient qui a besoin d'un traitement, comprenant l'administration d'une dose thérapeutiquement efficace de 1-(1-oxo-1,2-dihydroisoquinolin-5-yl)-5-(trifluorométhyl)-N-[2-(trifluorométhyl)pyridin-4-yl]-1H-pyrazole-4-carboxamide (composé A) ou d'un solvate ou d'une forme de sel pharmaceutiquement acceptable correspondant audit patient, ladite dose thérapeutiquement efficace étant définie dans la description. |
---|---|
AbstractList | The invention relates to a method of treating a disorder or condition that is affected by the inhibition of MALT1 in a subject in need of treatment, comprising administering a therapeutically effective dose of 1-(1-oxo-1,2-dihydroisoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]-1H-pyrazole-4-carboxamide (Compound A), or a solvate or pharmaceutically acceptable salt form thereof to said subject, wherein said therapeutically effective dose is defined in the specification.
L'invention concerne une méthode de traitement d'un trouble ou d'une affection qui est influencée par l'inhibition de MALT1 chez un patient qui a besoin d'un traitement, comprenant l'administration d'une dose thérapeutiquement efficace de 1-(1-oxo-1,2-dihydroisoquinolin-5-yl)-5-(trifluorométhyl)-N-[2-(trifluorométhyl)pyridin-4-yl]-1H-pyrazole-4-carboxamide (composé A) ou d'un solvate ou d'une forme de sel pharmaceutiquement acceptable correspondant audit patient, ladite dose thérapeutiquement efficace étant définie dans la description. |
Author | PHILIPPAR, ULRIKE WILLEMIN, MARIE E WILDE, THOMAS C GREWAY, ANTHONY T |
Author_xml | – fullname: PHILIPPAR, ULRIKE – fullname: GREWAY, ANTHONY T – fullname: WILLEMIN, MARIE E – fullname: WILDE, THOMAS C |
BookMark | eNqNjr1OwzAUhTPAwN873DGV8OCYBhjd-AbfyvENjoMalqpCZkJppfLSvAVp6dCR4Z4jfTqfdK-zi3E7pqvsp8Fo2QDXEAPqSP4FNFTsDUViD333R6LFoFvsI1XauQGwrrGK9IZguMOjbhEa7aIE8pYWFDnA0i9BlI9P87JUCnIJ4nC8YiHvC2HIDiYwdfzak2dHXszF4GZT5jFQ7XoOfPjvwLzIixOGM94OgcwkPhxFCVa0AwT9zg4nVumw4JVuyODsNrv83Hzt092pbzKoMVZWpN12nfa7zUca0_e60qqQhVLPWqp_TH4BW2ZXSg |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | METHODE DE TRAITEMENT D'UNE AFFECTION A L'AIDE D'UNE DOSE THERAPEUTIQUEMENT EFFICACE DE L'INHIBITEUR DE MALT1 JNJ-67856633 (1-(1-OXO-1,2-DIHYDROISOQUINOLIN-5-YL)-5-(TRIFLUOROMETHY L)-N-(2-(TRIFLUOROMETHYL)PYRIDIN-4-YL)-1 H-PYRAZOLE-4-CARBOXAMIDE) |
ExternalDocumentID | CA3212339A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CA3212339A13 |
IEDL.DBID | EVB |
IngestDate | Fri Sep 20 10:17:21 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CA3212339A13 |
Notes | Application Number: CA20213212339 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220909&DB=EPODOC&CC=CA&NR=3212339A1 |
ParticipantIDs | epo_espacenet_CA3212339A1 |
PublicationCentury | 2000 |
PublicationDate | 20220909 |
PublicationDateYYYYMMDD | 2022-09-09 |
PublicationDate_xml | – month: 09 year: 2022 text: 20220909 day: 09 |
PublicationDecade | 2020 |
PublicationYear | 2022 |
RelatedCompanies | JANSSEN PHARMACEUTICA NV |
RelatedCompanies_xml | – name: JANSSEN PHARMACEUTICA NV |
Score | 3.417323 |
Snippet | The invention relates to a method of treating a disorder or condition that is affected by the inhibition of MALT1 in a subject in need of treatment, comprising... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | METHOD OF TREATING A CONDITION USING A THERAPEUTICALLY EFFECTIVE DOSE OF THE MALT1 INHIBITOR JNJ -67856633 (1 -(1 -OXO-1,2-DIHYDROISOQUINOLIN-5-YL)-5-(TRIFLUOROMETHYL)-N-(2-(TRIFL UOROMETHYL)PYRIDIN-4-YL)-1 H-PY RAZOLE-4-CARBOXAMIDE) |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220909&DB=EPODOC&locale=&CC=CA&NR=3212339A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9swFBalG9ve1m5j3Y3zMEIKE7MtJY0ewlAkeVawJU9VStyXUicp9CUta8Z-8_7FJJNeXtoHG_OZI4wOR-dinU8IfV0ML-iQnI_wkhwlmB5RhltKMsyGactGHUVXLOhXZljM6HQ-mO-gy9temI4n9G9HjhgsahHsfdOt19f3RSzZ7a28-d5eBujqR-7HsrfNjrMsYQnryclY1VZa0RNiLHjPuDGJSzRhPCRKz2IUHWn21ckkNqVcP_Qo-Wv0vA6DrTd7aGe13kcvxe3Ba_voRbX93x0et6Z38wb9q5QvrASbg3eKe21-AgdhjdSxygTx_IyI-EI5XquZj0QHZQMhEFXC6xMF0h6rTrxQUPHSp6BNoSfaWwdTMwUcPEoIuwiBfgo4XnZucfotw1IXjXRWH9tfM21sqQ0e4KY8DPe-dzovZ9bZ-H0RM7ifbWF4gNeN0zII0k4whQLXDTh-aksVMMHdxM55paU6fIsgV14UOMzZ2Z1-zgS_m13yDu2ur9ar9whoSBUXGT1fkeUFZVnsS6SDtiVJshwFz8kO0MGjw3x44t1H9CoqutvnxT6h3c3vP6vPITDYtF86lf4HscSn8Q |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Nb9MwFLemgdhuMECMDfABVZ2ERRK7Hz5Uk2s7xCWxg-dODZdqaTtpl27aivib-S9mW93YBQ6xop_1LMdPz-8jfs8AfF70L0kfXwzREg8SRAaEopbgDNF-2tJhLNEVAvqV7hdTMpn1Zjvg6iEXJtYJ_R2LI3qJWnh538T9-uZvEEvEs5V3X9srD12f5m4kOlvvOMsSmtCOGI9kbYThHc5HnHW0HeGwRWPKvKP0bBCK8wbL6XwcklJunmqU_CV4XvvB1ptXYGe1PgB7_OHitQPwotr-7_avW9G7ew3-VNIVRkCTQ2clc0p_gwxyo4UKUSYY7s8IiCukZbWculDooGygN0Qld-pcQmHOZCQvJKxY6VKodKHGyhkLJ3oCkdco3uzCGHZTiMJjZgalXzIkVNEIa9SZ-TFV2pRKox5qyhPfdp1VeTk11oT5BUyjbraF4RO8bqwSnpBEwhQWqG6gZT9NKT3GmR2bGauUkCdvAMyl4wXyazZ_5M-cs8fVxW_B7vp6vXoHIPGu4iIjFyu8vCQ0C3mJpNe2OEmWQ6856SE4_Ocw7__T9wnsFa4q5_5bvx-B_cD0eOaLHoPdze2v1QdvJGzaj5G997e2qt4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=METHOD+OF+TREATING+A+CONDITION+USING+A+THERAPEUTICALLY+EFFECTIVE+DOSE+OF+THE+MALT1+INHIBITOR+JNJ+-67856633+%281+-%281+-OXO-1%2C2-DIHYDROISOQUINOLIN-5-YL%29-5-%28TRIFLUOROMETHYL%29-N-%282-%28TRIFL+UOROMETHYL%29PYRIDIN-4-YL%29-1+H-PY+RAZOLE-4-CARBOXAMIDE%29&rft.inventor=PHILIPPAR%2C+ULRIKE&rft.inventor=GREWAY%2C+ANTHONY+T&rft.inventor=WILLEMIN%2C+MARIE+E&rft.inventor=WILDE%2C+THOMAS+C&rft.date=2022-09-09&rft.externalDBID=A1&rft.externalDocID=CA3212339A1 |